Leptomeningeal carcinomatosis from esophageal cancer is a rare and clinically aggressive complication of solid tumors, characterized by heterogeneous presentation, frequent diagnostic delay, and poor prognosis.
A. Mylonakis, Dimosthenis Stylios, D. Tsilimigras et al.· Diseases of the esophagus· 0 citations
The trial did not meet its primary endpoint nor did it generate robust evidence of efficacy to warrant further assessment in unselected pancreatic cancer patients.
G. Papaxoinis, J. Sgouros, N. Korfiatis et al.· Cancer Treatment and Researc...· 0 citations
Immune checkpoint inhibitors (ICIs), including anti-PD-1 and anti-CTLA-4 agents, exhibit notable efficacy across various types of cancer. Nevertheless, they can trigger immune-related adverse events, among which immune-mediated liver injury (ILICI) occurs in 5-10% of patients. Corticosteroids are currently recommended...
M. Kyrkasiadou, A. Kyriazoglou, I. Kotsantis et al.· Experimental and Therapeutic...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.